Provider QP8-19 Addition of Drugs to the Oral Tetracycline Derivatives Prior Authorization Program Read More
Provider QP12-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Immune Globulins Read More
Provider QP9-19 Addition of Drugs to existing Prior Authorization with Quantity Limit Programs Read More
Provider QP10-19 Pharmacy Benefit Exclusion for Dymista, Duexis, Qbrexza, Vimovo, and Yosprala Read More
